#25: Regulatory Considerations for Drug Development: Current Status and Trend of IND/NDA Practice in China
The prices below are industry pricing. Reduced pricing may be available for Nonprofit/Academia and Government, subject to eligibility verification. Click Register to get pricing appropriate for your work setting. Review the cancellation and transfer policy.
- List Price: